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Abstract 
Introduction: Neurotrophins, as a family of proteins, are responsible for induction of the 
survival, development, and function of neurons. Also, neurotropic factors are growth factors 
like Neurotrophins that help neurons survive. Moreover, Neurotrophins differentiate between 
progenitor cells so that neurons are formed. Despite the fact that the majority of mammalian 
brain neurons are produced prenatally, the capability of growing new neurons from neural 
stem cells will be preserved by parts of the adult brain. This process is known as 
neurogenesis. Neurogenesis is stimulated and controlled by neurotrophins. 
Materials and methods: The recombinant plasmid transformed to E.coli ´ cell and colonies 
that contain plasmid were selected by Colony PCR. Enzyme digestion and sequencing were 
monitored to approve the accuracy of extracted plasmid of the clones. 
Results: Plasmid was verified correctly. Based on RT-PCR and western blotting, the 
transcription of NTF4 gene and the expression of NTF4 protein after transfection were 
proved.  
Conclusion: Plasmid was correctly constructed, CHO Cells were successfully transfected by 
transfection, and protein could be properly expressed. The results provided a solid foundation 
for the studies in the area of the transplantation of gene-modified CHO Cells to further spinal 
cord regeneration. 
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Introduction 
Neurotrophins, as a family of growth 
factors, are necessary for neurons’ survival 
and maintenance (1). Nerve growth factor, 
brain-derived neurotropic factor (BDNF), 
neurotrophin-3 (NT3), and neurotrophin-
4/5 (NTF4) are members of this family. 
Neurotrophins have various functions that 
are mediated by binding to high-affinity 
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tyrosine kinase receptors and low-affinity 
p75NTR receptor that have distinct 
specificities: the TrkA receptor transfers 
nerve growth factor signals, both BDNF 
and NTF4 bind to the TrkB receptor, and 
NT3 interacts mainly with TrkC (2, 3).The 
expression of the neurotrophin 
components that signal pathway is not 
observed only in neural tissues; it 
designates that neurotrophins have 
functional roles in other organ systems, as 
well (4). A cursory perusal of the related 
literature revels that gene transfer studies 
have made use of a wide range of 
mammalian cell types. Recently, it has 
growingly become significant to introduce 
transfection reagents that can enable 
highly efficient DNA uptake into a broad 
spectrum of cell types (5). Chinese 
hamster ovary (CHO) cells are cell lines 
that are derived from the Chinese hamster 
ovary. Biological and medical research 
frequently makes use of CHO cells and so 
do therapeutic companies for commercial 
production of therapeutic proteins. 
Introduced in the 1960s, these cells are 
grown as a cultured monolayer and in their 
culture medium they need the amino acid 
proline. Also, studies in the areas of 
genetics, toxicity screeching, nutrition, and 
gene expression, specifically those studies 
that aim at expressing recombinant 
proteins, use CHO cells(6). Currently, in 
order to produce recombinant protein 
therapeutics, the most frequently used 
mammalian host is CHO cells. The present 
research was carried out to study the 
transiently transfect pET28a-LIC-NTF4 in 
the CHO cells in order to use in gene 
therapy.  
Materials and methods 
Sub-Cloning: The carrier vector was 
primarily transformed in the DH5–α sosh 
of Escherichia coli strain. After the 
bacteria were transformed, they were 
cultured in Luriani berant (L.B) medium 
inside a shaker incubator. Ampicilin was 
added to the medium, too. The day after, 
the proliferated bacteria were prepared to 
extract plasmid. Through high pure 
plasmid isolation (Fermntase), the 
recombinant plasmid was extracted and 
then subjected to electrophoresis on 0.1% 
agarose gel. The plasmid was digested via 
HindIII and NotI enzymes, and the 
products were separated by electrophoresis 
with a low-melting-point agarose gel. 
PCR: The PCR mix contained 0.5 μg of 
DNA, 0.1 mM dNTP, 1.5 mM MgCl2, 20 
pmole of each specific forward and reverse 
primers (Forward 5′- GAG CTC ATT 
CGA CGT CTT CTG CGA-3′ and 
Reverse 5′- GAA TCC TCA GGA CCG 
GGT AA CGC-3′), and 1.25 units of Taq 
DNA polymerase in a final volume of 
50μl. PCR was carried out within 30 
cycles: denaturation at 94°C for 30 s, 
annealing at 65°C for 30 s, and elongation 
at 70°C for 40 s. The PCR product was 
then subjected to electrophoresis on 1% 
agarose gel, stained with ethidium 
bromide, and visualized under ultraviolet 
light. DraIII and BamHI restriction sites 
were then added to the 5′ end sequences of 
the forward and reverse primers, 
respectively. PCR product was purified, 
sequenced, and deposited to Gene Bank.  
Ligation: After confirmation, they NTF4 
were prepared for ligation to expression 
vector. The gene particle, proliferated by 
PCR, was clarified via clean up gene kit. 
The expression vector was cultured 
simultaneously to proliferate in L.B 
medium and transformed to linear form 
making use of Hind III enzyme. The gene 
particle ligated to the vector using T4 
DNA ligase. The ligation product was then 
incubated at 4 degrees for one night and 
was then inserted into the process of 
transformation. 
Colony PCR: In order to verify that the 
gene entered the destination vector, the 
bacteria were cultured on the plates 
containing antibiotic. The proliferated 
colonies entered the colony PCR stage. 
The proliferated colonies on the antibiotic- 
containing plates were picked via a 
sampler and were inserted into a microtube 
along with revers and forward primers and 
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Taq DNA polymerase and were then put 
inside the thermocycler machine. The PCR 
product ran on agarose gel and those 
positive samples which produced a distinct 
band were transferred to L.B. medium-
containing antibiotic. The product was 
purified via highly pure plasmid isolation 
kit the same day. Two simultaneous 
enzymes that had a common buffer were 
used to analyze the recombinant plasmid. 
The site of action for these enzymes was 
located at the two sides of the inserted 
particle on the plasmid. The samples were 
incubated for one hour at 37 degrees and 
all were ran on the gel. 
Digestion and sequencing: As the final 
confirmation of recombinant plasmid 
following the extraction via kit, those 
plasmids showing a correct pattern in 
enzymal analysis were sent to Seq Lab 
Company in China for sequencing 
procedure making use of the universal 
primers. The results of the sequencing 
were assessed using Blast program 
(www.ncbi.nlm.nih.gov/blast) to be 
matched with the genetic bank genes. 
Transfection: CHO cells were cultured in 
Ham s F10 (Gibco-BRL,Scotland) that 
were supplemented with 10% FCS (Gibco-
BRL,Scotland) , 100 u/ml penicillin and 
100 μg/ml streptomycin. Then, in order to 
import gene into the cells, the transfection 
method was used. The designed gene was 
imported into the plasmid and then the 
plasmid was transferred to the CHO. The 
transfection was carried out in 6 
chambered petries in which the cells were 
cultured between 24–48 hours ago. During 
the transfection, the cells population was 
about 2.5 8 105 in each petri. A standard 
kit was used for liposomes to perform the 
transfection. The authors used 
lipofectamin ragin. One microgram of 
plasmid DNA was added to 350 
microgram of a serum-free medium and 
was left in room temperature for 30 
minutes. At the same time, 10 micro grams 
of lipofectamin was added to 350 
micrograms of medium and was left for 30 
minutes in room temperature. Then, these 
two tubes were mixed up and the product 
was incubated at 37 degrees for 1 hour. 
Then, the content of microtube was thrown 
on the cells. The cells were then incubated 
for 4 hours after which medium and serum 
were added to the cells and were incubated 
for 48 hours. The medium of cells was 
exchanged one day after transfection. In 
the present study, SDS-page and Western 
Blotting tests were utelized in order to 
trace the recombinant protein in eukaryotic 
systems. 
RT-PCR: The expression of NTF4 in 
transfected and non-transfected CHO 
groups was examined via RT-PCR. In 
order to extract total RNA, RNA kit 
(Invitrogen) was used. The extracted RNA 
was then treated by DNaseI (Invitrogen) to 
obtain purified RNA. Next, the purified 
RNA was analyzed via spectroscopy and 
agarose gel electrophoresis. Next, 
according to the manufacturer’s 
instruction, 1000 ng extracted RNA was 
used to synthesize 20 μl first strand cDNA 
(Fermentas) of cDNA (500 ng) was used 
for PCR (Master Mix, 2×, Fermentas) 
using a thermo cycler (Bio RAD) for 35 
cycles. As a negative control, cDNA was 
omitted from the reaction. The product 
size of PCR was analyzed by 2% agarose 
gel electrophoresis. 
Results  
NTF4 sub-cloning: The Sequencing data 
revealed the proNTF4 gene has precisely 
subcloned into the pET28a-LIC- NTF4 to 
construct pET28a-LIC- NTF4 vector with 
no mutation. Also, sequencing data 
analyses of the inserted proNTF4 in the 
expression vector confirmed the validity of 
the sequence of NTF4 gene as published 
by Uniprot and GenBank bioinformatics 
databases (Fig. 1, 2, 3). 
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Figure 1. Purification of plasmid pET28a-LIC- NTF4. A, ladder and B, plasmid pET28a-LIC- 
NTF4 after digestion  
Figure 2. PCR amplification at different temperatures and optimized temperature of 70Cº. Lane 
A,  ladder 100bp and Lane B,  PCR product 
Original article                                                              J Bas Res Med Sci 2014; 1(4):34-41 . 
 
38 
 
            
 
 
 
 
 
 
 
 
 
Enzyme digestion of pET28a/NTF4: The 
cloned recombined plasmid was named 
pET28a/NTF4. Theoretically, by 
restricting enzyme EcoR I and BamH I, 
PET28A/NTF4 must have two fragments. 
According to the results, it was shown that 
the size of the recombinant plasmid and 
restriction fragments corresponded with 
the theoretical value, meaning that NTF4 
was successfully combined (Fig.4).  
Stable transfection of CHO Cells with 
expression vector: When Kanamycin was 
added to the medium at optimum 
concentration, the individual antibiotic-
resistant CHO colonies appeared. The cells 
were then subjected to further analysis. 
 
 
 
 
 
 
 
 
 
 
A B C D 
Figure 3. Clooney-PCR on plasmid recombinant. Lane A, ladder 100bp and lane B, PCR product 
Figure 4. Enzymatic digestion of recombinant plasmid via SmaI enzyme. Lane 1, Marker 100bp 
and  lane 2,  plasmid 
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SDS-PAGE and Western blot results: 
SDS-PAGE analyses of the stable 
transfected CHO Cells led to the detection 
of NTF4 expression in the lysate. 
Additionally, semi-quantitative Western-
blot data analysis showed that the NTF4 
synthesis and secretion in the transfected  
CHO Cells (Fig. 5).  
 
Figure 5.  Western blotting of NTF4 Gene. 
Discussion In the present study, the 
recombinant vector containing fusion gene 
NTF4 was successfully constructed via 
molecular biology techniques. The 
findings pave the way and provide the 
basis for further research in the field of 
Surviving for gene therapy. NTF4 is a type 
of neuropoietic cytokine. Survival and 
differentiation of several cell types such as 
sensory, sympathetic, and motor neurons 
are induced via NTF4 (1,2,3). It is also 
used as a protein in the pathogenesis of 
regenerative diseases (4,5). Yet, contrary 
to the mice that lack NTF4, those that have 
a homozygous null mutation in the gene 
that encode the NTF4Rα chain die 
perinatally and present severe motor 
neuron deficits (3). This data suggests that 
there exists a second NTF4R ligand that 
has a grave role in development of the 
neonatal nervous system (6, 7). So far, 
several researchers have studied neuron 
growth factors and protective agents (8). 
Multiple experimental and animal models 
have proven that neuronal growth factors 
have protective effects on diseases related 
to central nervous system like strokes, 
traumatic lesions, and neurodegenerative 
problems (9) and some of these neuronal 
growth factors have already been 
implemented in certain clinical 
applications, e.g. Neurotrophins (10). 
Some neuronal growth factors such as 
Neurotrophins (NT) have already clinical 
applications (11). Neurotrophins are 
among groups of proteins whose 
responsibility includes development, 
surveillance, and death of various 
communities of dopaminergic, sensory, 
and motor neurons (12,13). It has been 
shown that these factors have trophic 
effect on nervous system growth, however 
how the protective effects of these factors 
work exactly has remained unknown. One 
of the members of neurotrophic factors 
family is NTF4 (14,15). The NTF4 gene is 
expressed in glial cells of central and 
peripheral nervous system. It has roles in 
expressing gene and watching over and 
developing different types of neurons (16). 
NTF4 concentration increases prior to 
birth and if NTF4 gene is depleted or 
mutated, many nervous system diseases, 
such as Huntington will be inevitable (17). 
The NTF4 gene is also considered in 
breast cancer, and leads to surveillance and 
growth of neoplastic cells (18).According 
to the recent studies, NTF4 has a 
protective autocrine effect on CNS injured 
neurons (19). The results obtained from 
immunohistochemical studies have show 
NTF4 protein can be expressed via 
transplanted cells transfected by NTF4 
gene. Hoane et al, made an attempt to 
increase the neurotrophic efficacy of NTF4 
gene and reached promising results (20). 
They first differentiated rat emberional 
stem cells to neural and glial progenitors 
and then by cloned and transfected NTF4 
gene to this cells and then injected them 
into the injured site of the animal via CCI 
technique. It is reported that by 
transplanting this differentiated stem cells 
to the injured site, sensory and motor 
behaviors of rats could improve within 2-4 
weeks and the injury extender reduced 
significantly after 40 days (21). Gene 
cloning and transfecting is integral in 
biological and developmental researches 
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as well as diagnosis, prevention, and 
treatment of neurogenic diseases (22). 
Conclusion  
The results of the present study prove 
Transfection Reagent are easy to use and 
give higher transfection efficiencies for 
CHO cells. This activated reagent potential 
to deliver NTF4 into CHO cells. 
Additionally, the result showed that the 
recombinant vector had the ability for 
transfection in CHO cells and thus this 
vector can be utilized in gene therapy.
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